Personal information

Verified email domains

Activities

Works (4)

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

BMC Cancer
2022-09-24 | Journal article
Contributors: Farastuk Bozorgmehr; Petros Christopoulos; Inn Chung; Jelena Cvetkovic; Manuel Feißt; Johannes Krisam; Marc A. Schneider; Claus Peter Heußel; Michael Kreuter; Daniel W. Müller et al.
Source: check_circle
Crossref

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Lung Cancer
2020-10 | Journal article
Contributors: P. Christopoulos; M. Kirchner; J. Roeper; F. Saalfeld; M. Janning; F. Bozorgmehr; N. Magios; D. Kazdal; A.L. Volckmar; L.M. Brückner et al.
Source: check_circle
Crossref

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

BMC Cancer
2020-08-26 | Journal article
Contributors: Farastuk Bozorgmehr; Inn Chung; Petros Christopoulos; Johannes Krisam; Marc A. Schneider; Lena Brückner; Daniel Wilhelm Mueller; Michael Thomas; Stefan Rieken
Source: check_circle
Crossref

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

BMC Cancer
2019-12 | Journal article
Contributors: Farastuk Bozorgmehr; Adriane Hommertgen; Johannes Krisam; Felix Lasitschka; Jonas Kuon; Martin Maenz; Peter E. Huber; Laila König; Meinhard Kieser; Juergen Debus et al.
Source: check_circle
Crossref

Peer review (2 reviews for 1 publication/grant)

Review activity for BMJ open. (2)